Built on recent guidelines
LeukoVantage is a panel that offers physicians testing solutions for these disease states: acute myeloid leukemia (AML), myeloproliferative neoplasms (MPN), myelodysplastic syndrome (MDS) and other myeloid neoplasms. Based on a comprehensive literature review and updated guidelines for gene inclusion from the World Health Organization and National Comprehensive Cancer Network®, the analyzed genes can help physicians make a more informed diagnosis and more closely monitor disease progression and their patients’ response to treatment.1-4
These 4 panels can help: